stock.name

Repligen Corp.

RGEN

Market Cap$11.14B
Close$

Compare Repligen

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Repligen Corp.Repligen Corp.267.90%2%16.80.3
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$208.57

Current Fair Value

12.9% upside

Undervalued by 12.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$11.14 Billion
Enterprise Value$10.97 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.74
Beta1.41
Outstanding Shares55,771,075
Avg 30 Day Volume428,202

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio267.93
PEG-175.92
Price to Sales16.8
Price to Book Ratio5.28
Enterprise Value to Revenue17.17
Enterprise Value to EBIT456.87
Enterprise Value to Net Income263
Total Debt to Enterprise0.05
Debt to Equity0.29

Revenue Sources

No data

ESG Score

No data

About Repligen Corp.

CEO: Anthony Hunt